The World Health Organization (WHO) on Monday announced that Nepal has successfully eliminated rubella, also known as German measles, as a public health problem. This achievement marks a significant step forward in the country’s efforts to protect its population from vaccine-preventable diseases.
Rubella is a highly contagious viral infection that poses a serious threat to pregnant women, as it can lead to miscarriage, stillbirth or severe and lifelong birth defects. The disease, however, is preventable with safe and cost-effective vaccines.
“Nepal’s success reflects the unwavering commitment of its leadership, the persistent efforts of health workers and volunteers, and the unstinting support of engaged and informed communities,” said Dr Catharina Boehme, Officer-in-Charge of WHO South-East Asia. She endorsed the recommendation of the Regional Verification Commission for Measles and Rubella elimination (SEA-RVC), which verified Nepal’s achievement.
The SEA-RVC held its annual meeting from July 22-24, where it reviewed and evaluated data submitted by Nepal’s national verification committee on disease surveillance and immunization coverage rates before recommending verification of rubella elimination.
Nepal is the sixth country in the WHO South-East Asia region to achieve this milestone. The region has prioritized the elimination of measles and rubella as public health problems by 2026. Prior to Nepal, Bhutan, DPR Korea, the Maldives, Sri Lanka and Timor-Leste from the region had eliminated rubella.
“Nepal’s achievement of rubella elimination is yet another testament to the success of the national immunization program, which has long been one of the strongest pillars of our healthcare system,” said Pradip Paudel, Minister for Health and Population. He acknowledged the steadfast support from Gavi and WHO and called on all stakeholders to continue their efforts to ensure no child in Nepal suffers from a vaccine-preventable disease.
Nepal first introduced the rubella-containing vaccine into its immunization program in 2012. Subsequent nationwide campaigns in 2016, 2020, and 2024 helped the country achieve over 95 percent coverage for at least one dose of the vaccine by 2024, despite challenges resulting from the Covid-19 pandemic and the 2015 and 2023 earthquakes.
Innovative strategies, such as ‘immunization months’ and outreach programs to vaccinate missed children, provided additional momentum. Nepal also recently introduced a robust laboratory testing algorithm, the first in the WHO South-East Asia Region, to further strengthen surveillance.
“Congratulations to Nepal for eliminating rubella. This public health achievement is the result of close collaboration between the government, dedicated health workers, partners, and communities,” said Dr Rajesh Sambhajirao Pandav, WHO Representative to Nepal. “WHO is proud to have contributed to this journey and remains committed to supporting Nepal in sustaining this accomplishment.”
The Regional Verification Commission for Measles and Rubella elimination in South-East Asia Region (SEA-RVC) was established in March 2016 to monitor progress toward measles and rubella elimination. The WHO says that the National Verification Committees of countries in WHO South-East Asia Region report on annual progress made towards achieving the goal of measles and rubella elimination which is then reviewed by SEA-RVC which provides suggestions and recommendations or verify them as achieved the status of measles and rubella elimination.
In 2013, the WHO South-East Asia Region set the goal to eliminate measles and control rubella by 2020. In 2019 the goal was revised to measles and rubella elimination by 2023. In view of setbacks during Covid-19 pandemic, in 2024, member countries agreed to extend the target for elimination of measles and rubella, aspiring to achieve by 2026.
